Research study Program year 2020 Source: CMS Open Payments

M16-183

ClinicalTrials.gov NCT03484520

Research payments

$949,145

97 payments

Through program year 2020, $949,145 in research payments was reported against M16-183, across 97 payments, paid by AbbVie, Inc..

Paid by: AbbVie, Inc.
ClinicalTrials.gov: NCT03484520

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$292,767	52
2019	Research	$656,378	45

Breakdown

Who paid Research payments · program years 2019–2020

AbbVie, Inc. $949,145 97 payments

Who received the money Research payments · program years 2019–2020

Ohio State University Organisation paid for research $270,794 26 payments
State of Maryland Organisation paid for research $174,998 13 payments
University Of Chicago Hospitals Organisation paid for research $150,672 17 payments
Wake Forest University Organisation paid for research $98,067 8 payments
Ronald Reagan Ucla Teaching hospital · CA $88,917 10 payments
Ut Md Anderson Cancer Center Teaching hospital · TX $83,661 4 payments
Dcam Outpatient Pharmacy Organisation paid for research $50,323 11 payments
Uams Medical Center Teaching hospital · AR $24,725 2 payments
Wake Forest University Student Health Services Organisation paid for research $6,988 6 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

7 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.